Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 3798 | 2014 |
Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 1945 | 2016 |
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group B Dubois, N Villain, GB Frisoni, GD Rabinovici, M Sabbagh, S Cappa, ... The Lancet Neurology 20 (6), 484-496, 2021 | 784 | 2021 |
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases HM Lanoiselée, G Nicolas, D Wallon, A Rovelet-Lecrux, M Lacour, ... PLoS medicine 14 (3), e1002270, 2017 | 569 | 2017 |
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ... Alzheimer's & Dementia 15 (3), 465-476, 2019 | 376 | 2019 |
Pure alexia as a disconnection syndrome: new diffusion imaging evidence for an old concept S Epelbaum, P Pinel, R Gaillard, C Delmaire, M Perrin, S Dupont, ... cortex 44 (8), 962-974, 2008 | 336 | 2008 |
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World … P Lewczuk, P Riederer, SE O’bryant, MM Verbeek, B Dubois, PJ Visser, ... The world journal of biological psychiatry 19 (4), 244-328, 2018 | 265 | 2018 |
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ... The Lancet Neurology 17 (4), 335-346, 2018 | 217 | 2018 |
EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease S Gaubert, F Raimondo, M Houot, MC Corsi, L Naccache, J Diego Sitt, ... Brain 142 (7), 2096-2112, 2019 | 195 | 2019 |
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 155 | 2019 |
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 151 | 2022 |
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020 H Hampel, S Lista, SJ Teipel, F Garaci, R Nisticò, K Blennow, ... Biochemical pharmacology 88 (4), 426-449, 2014 | 151 | 2014 |
Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: a feasibility study C Boutet, M Chupin, S Lehéricy, L Marrakchi-Kacem, S Epelbaum, ... NeuroImage: Clinical 5, 341-348, 2014 | 125 | 2014 |
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: recommendations of an expert panel C Babiloni, X Arakaki, H Azami, K Bennys, K Blinowska, L Bonanni, ... Alzheimer's & Dementia 17 (9), 1528-1553, 2021 | 120 | 2021 |
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total-tau, phosphorylated-tau, NFL … H Hampel, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ... Alzheimer's & Dementia 14 (4), 492-501, 2018 | 99 | 2018 |
Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints E Cavedo, PA Chiesa, M Houot, MT Ferretti, MJ Grothe, SJ Teipel, S Lista, ... Alzheimer's & Dementia 14 (9), 1204-1215, 2018 | 91 | 2018 |
Free and Cued Selective Reminding Test–accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: a large-scale biomarker-characterized monocenter … M Teichmann, S Epelbaum, D Samri, ML Nogueira, A Michon, H Hampel, ... Alzheimer's & dementia 13 (8), 913-923, 2017 | 91 | 2017 |
Predicting the progression of mild cognitive impairment using machine learning: a systematic, quantitative and critical review M Ansart, S Epelbaum, G Bassignana, A Bône, S Bottani, T Cattai, ... Medical Image Analysis 67, 101848, 2021 | 88 | 2021 |
Preclinical Alzheimer's disease: a systematic review of the cohorts underlying the concept S Epelbaum, R Genthon, E Cavedo, MO Habert, F Lamari, G Gagliardi, ... Alzheimer's & Dementia 13 (4), 454-467, 2017 | 82 | 2017 |
17q21. 31 duplication causes prominent tau-related dementia with increased MAPT expression K Le Guennec, O Quenez, G Nicolas, D Wallon, S Rousseau, AC Richard, ... Molecular Psychiatry 22 (8), 1119-1125, 2017 | 74 | 2017 |